ClinicalTrials.Veeva

Menu

FAMILY INHERITANCE, GENE-GENE AND GENE-ENVIRONMENT INTERACTIONS IN THE FIELD OF CARDIOVASCULAR AND RENAL DISEASES. Fifth Visit of the STANISLAS Cohort

C

Central Hospital, Nancy, France

Status

Enrolling

Conditions

Genotype
Nutrition
Risk Factors
Cohort Studies
Cardiovascular Diseases

Treatments

Other: Cardiovascular assessment
Behavioral: Dietary intake
Behavioral: A questionnaire on eating behaviors
Other: A questionnaire on the "perception of the management of cardiovascular risk factors"
Behavioral: Assessment of compliance with antihypertensive treatments for treated participants
Biological: 24 hours urinary collection
Other: General questionnaires
Other: Ambulatory 24 hours measurment of blood pressure
Behavioral: Epworth Sleepiness Scale
Biological: Capillary sampling
Genetic: Blood samples
Dietary Supplement: A questionnaire on food supplements use
Behavioral: Women specific questionnaire
Diagnostic Test: NYHA dyspnea questionnaire
Other: SARS-CoV-2 Infection Questionnaire
Other: Hemodynamic parameters
Behavioral: A questionnaire on eating habits to determine consumer profiles
Other: Anthropometric parameters
Behavioral: Anxiety questionnaire
Other: Instantaneous expired air analysis
Biological: Blood and urine samples

Study type

Interventional

Funder types

Other

Identifiers

NCT05916287
2021-A00449-32 (Other Identifier)
2020PI129

Details and patient eligibility

About

The Stanislas Cohort is a monocentric familial longitudinal cohort originally comprised of 1006 families consisting of two parents and at least two biological children and deemed healthy, recruited in 1993-1995 at the Centre for Preventive Medicine of Nancy. This cohort was established with the primary objective of investigating gene-gene and gene-environment interactions in the field of cardiovascular diseases. The 5th visit of the STANISLAS Cohort will allow a better evaluation of the cardiovascular ageing of the population and the transition toward cardiovascular or renal diseases in relation with their genetic profile and environment.

Full description

The main objective of the STANISLAS cohort is to identify the factors associated with cardiovascular aging (assessed through the study of the degradation of morphological and functional parameters of the heart and vascular systems).

Data (clinical, biological, morphological, genetic and lifestyle) from previous visits (the first having been initiated in the mid-1990s) will be considered as exposure and / or adjustment variables.

The exposure variables of interest will be:

  • The components of metabolic syndrome (MS),
  • Genetic determinants, through an approach of family segregation and candidate genes,
  • Multi-omic biomarkers analyzed from the biological collection of the first assessments of the cohort
  • Food intake, nutrition and eating behavior

The secondary objectives are

  • Identify the factors associated with a degradation of renal parameters (renal function and proteinuria).
  • Identify the factors associated with a degradation of metabolic parameters.
  • To assess the association between SARS-CoV-2 infection (questionnaire and serological approach) and cardiovascular and renal parameters
  • Identify factors associated with the occurrence of clinical cardiovascular events.
  • Association between Covid 19 events and general disabling symptoms
  • Complete the cohort's biological collection for future biomarker assays related to previous objectives

Enrollment

3,000 estimated patients

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • aged over 18
  • Person who participated in the Stanislas Cohort
  • Person affiliated to a social security scheme or beneficiary of such a scheme
  • Person having received complete information on the organization of the research and having signed an informed consent

Exclusion criteria

  • Persons deprived of their liberty by a judicial or administrative decision, persons undergoing psychiatric treatment under Articles L. 3212-1 and L. 3213-1

  • Person referred to in Articles L. 1121-5, L. 1121-7 and L1121-8 of the Public Health Code:

    • Pregnant woman, parturient or nursing mother
    • Adult person subject to a legal protection measure (guardianship, curatorship, safeguard of justice)
    • Person of full age unable to express consent

Trial design

Primary purpose

Other

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

3,000 participants in 1 patient group

Healthy volonteer
Experimental group
Treatment:
Behavioral: Anxiety questionnaire
Other: Anthropometric parameters
Other: Hemodynamic parameters
Behavioral: Women specific questionnaire
Other: Hemodynamic parameters
Genetic: Blood samples
Biological: Blood and urine samples
Other: Cardiovascular assessment
Behavioral: Dietary intake
Dietary Supplement: A questionnaire on food supplements use
Behavioral: Women specific questionnaire
Other: General questionnaires
Other: Ambulatory 24 hours measurment of blood pressure
Biological: 24 hours urinary collection
Diagnostic Test: NYHA dyspnea questionnaire
Behavioral: A questionnaire on eating habits to determine consumer profiles
Other: Instantaneous expired air analysis
Behavioral: A questionnaire on eating behaviors
Behavioral: Epworth Sleepiness Scale
Other: Hemodynamic parameters
Other: Hemodynamic parameters
Biological: Capillary sampling
Other: SARS-CoV-2 Infection Questionnaire
Other: A questionnaire on the "perception of the management of cardiovascular risk factors"
Behavioral: Assessment of compliance with antihypertensive treatments for treated participants

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems